Evercore ISI Downgrades Chinook Therapeutics (KDNY) to In Line
Tweet
Share
E-mailGet Alerts KDNY Hot Sheet
Price: $40.39 --0%
Rating Summary:
2 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
2 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Evercore ISI analyst Josh Schimmer downgraded Chinook Therapeutics (NASDAQ: KDNY) from Outperform to In Line with a price target of $40.00 (from $30.00).
For an analyst ratings summary and ratings history on Chinook Therapeutics click here. For more ratings news on Chinook Therapeutics click here.
Shares of Chinook Therapeutics closed at $37.87 yesterday.
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Va Tech Wabag Ltd. (VATW:IN) PT Raised to INR2,410 at ICICI Securities
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
